UK 16:14 Monday, 26 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Self important fund manager Neil Woodford flagged up concerns about biotech valuations the other day. Discussing inter alia Plethora (PLE) another bit of a disappointment for my good friend Jim Mellon I look at how investors do and should value such stocks and tend to agree with Woodford that right now risk reward are out of kilter.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments
David Russell
I invest in biotech because you are putting money into helping that company solve a medical problem and you could end up making some money back. If you give to a charity you are guaranteed nothing back. If you are investing in biotech it’s about believing in what they do and not about the money and that’s my aspect on investing in the biotech. I do not give to charities but invest in the companies that could solve the problems and care very little about getting my money back on this sector. Good Bearcast by the way.:)
Tim reynolds
Tom
I enjoy your Bearcasts . Whilst you may be correct about plethora it would seem you have an unhealthy and potentially biased view of anything to do with Jim Mellon clearly from your historic dealings . I can understand if you make quick jibes which in general fit in to your way of journalism . As a suggestion You should personally refrain from analysing his investments as it may be seen by your audience to be a personal vendetta . There’s so many other bear stocks to concentrate your efforts on . Any analysis of jm related stocks may rightly or wrongly make people think you have alterior motives and detract from your good work and Could lead to question your integrity . Perhaps integrity is not the correct word but i hope you get my drift.
Regards
Tom Winnifrith
Tim
I have tipped Jim Mellon stocks in the past. And praised him where praise is due. But the times they are a changing. Watch that French video. Things are happening. I am not going to miss out on this one.
T